▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2848 by analyst upside · 2026-11-12
ICLR
ICON Public Limited Company
Healthcare · Market Cap $15B · P/E 81.8x
ANALYST PRICE TARGET
+15.8%
implied upside to consensus target
Current Price $199.7
Consensus Target $231.29
Bull Target $268.0
Bear Target $180.0
Analysts Covering 17
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
8
Hold
7
Sell
1
52-Week Low $66.57
52-Week High $219.04
YTD Return +5.8%
FUNDAMENTALS
Market Cap $15B
P/E Ratio (TTM) 81.8x
Forward P/E 17.2x
EPS (TTM) $2.44
PEG Ratio 0.56
Dividend Yield N/A
Revenue (TTM) $8.2B
Profit Margin 5.3%
52-WEEK RANGE
52-Week Low $66.57
52-Week High $219.04
Current Price $199.7
Bear Target $180.0
Bull Target $268.0
● Now $199.7 ● Target $231.29
TRADING DATA
Avg Volume 961K
YTD Return +5.8%
Analyst Count 17
Consensus Buy
Upside to Target +15.8%
Last Updated 2026-11-12

ANALYST SUMMARY

ICON Public Limited Company (ICLR) is currently trading at $199.7 with a Wall Street consensus price target of $231.29, implying potential upside of 15.8% over the next 12 months. 17 analysts currently cover ICLR, with a consensus rating of Buy - 53% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $268.0, while the most cautious has a target of $180.0.

ICLR operates in the Healthcare sector with a market capitalisation of $15B. The stock is up 5.8% year-to-date and is currently trading near the upper end of its 52-week range of $66.57 – $219.04.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for ICLR, with each firm's 90-day track record across all stocks we track. See full firm rankings →

RBC Capital - Reiterated
Outperform → Outperform 2026-10-29 Building track record
Citigroup - Reiterated
Neutral → Neutral 2026-10-29 Building track record
TD Cowen - Reiterated
Buy → Buy 2026-10-29 Building track record
UBS - Reiterated
Neutral → Neutral 2026-10-29 33% win rate (6 calls)
Barclays - Reiterated
Equal-Weight → Equal-Weight 2026-10-29 Building track record
Truist Securities - Reiterated
Buy → Buy 2026-10-29 Building track record
Baird - Reiterated
Outperform → Outperform 2026-10-29 Building track record
Citigroup - Reiterated
Neutral → Neutral 2026-09-18 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
50
out of 100
Coverage depth
22/30
Consensus clarity
21/30
Vote unanimity
5/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →